GSK

BRIEF-GSK gets positive phase 2b data on asthma drug - 12/02 - 08:36 AM ET

Business travel to India on hold - 12/01 - 11:07 AM ET

Philadelphians scramble to see Obama inauguration - 12/01 - 03:37 AM ET

Obama may tap Duke doctor: Califf mentioned as FDA candidate - 11/28 - 04:45 AM ET

BRIEF: More bad news for Avandia - 11/27 - 04:47 AM ET

BRIEF-Glaxo says not involved in latest EU raids - 11/25 - 01:44 PM ET

Dr Reddy's introduces generic Imitrex tablets in US - 11/25 - 11:42 AM ET

Study: Avandia riskier than Actos for older diabetics - 11/25 - 03:47 AM ET

UPDATE 1-Safety risks higher with Avandia than Actos -study - 11/24 - 10:16 PM ET

Safety risks higher with Avandia than Actos -study - 11/24 - 04:02 PM ET

GSK and Neptunus to form JV for co-development of flu vaccines - 11/24 - 07:08 AM ET

The News & Observer, Raleigh, N.C., Tim Stevens column: Enloe senior's scoring grabs attention - 11/23 - 05:26 AM ET

GSK wins FDA approval for platelet drug - 11/21 - 09:37 AM ET

AstraZeneca to divest Swedish OTC portfolio to GlaxoSmithKline - 11/21 - 09:35 AM ET

GlaxoSmithKline Rises In Pre-Market On FDA Approval Of Oral Medication, JV Deal With Neptunus - 11/21 - 08:22 AM ET

UPDATE 1-Glaxo forms Chinese flu vaccine joint venture - 11/21 - 05:48 AM ET

BRIEF-GlaxoSmithKline forms Chinese flu vaccine JV - 11/21 - 05:08 AM ET

UPDATE 1-Glaxo wins U.S. approval for platelet drug - 11/20 - 07:14 PM ET

Glaxo wins U.S. approval for platelet drug - 11/20 - 06:55 PM ET

FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder - 11/20 - 05:43 PM ET

Page 1 of 15     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index